Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT01999829
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 110 participants
- Registry
-
NCT01999829
-
- Other papers using this trial's data
- Peri-operative oral caffeine does not prevent postoperative atrial fibrillation after heart valve surgery with cardiopulmonary bypass: A randomised controlled clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01999829. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- citrate of caffeine
- Intervention (Drug)
- placebo
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
Record details
- Record id
cardio:ct-nct01999829- Content hash
5a17b04f8542532a84cba7ba1c9c6b31f6263149ec79d2f2e34f95dde1c31152